Hemodialysis impairs endothelial function via oxidative stress: Effects of vitamin E-coated dialyzer

Circulation

Volumn 101, Issue 9, 2000, Pages 1002-1006

  Miyazaki, Hiroshi ^a   Matsuoka, Hidehiro ^a   Itabe, Hiroyuki ^b   Usui, Michiaki ^a   Ueda, Seiji ^a   Okuda, Seiya ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

Antioxidants; Atherosclerosis; Kidney; Lipoproteins; Vasodilation

Indexed keywords

ALPHA TOCOPHEROL;

ADULT; ARTICLE; ARTIFICIAL KIDNEY; ATHEROSCLEROSIS; BLOOD TRANSFUSION; BLOOD VESSEL TONE; CELL FUNCTION; CELL PROLIFERATION; CLINICAL ARTICLE; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; HEMODIALYSIS; HUMAN; LIPOPROTEIN METABOLISM; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; VASODILATATION;

EID: 0034051716     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.9.1002     Document Type: Article

References (43)

1. Raine AE, Margreiter R, Brunner FP, Ehrich JH, Geerlings W, Landais P, Loirat C, Mallick NP, Selwood NH, Tufveson G, Valderrabano F. Report on management of renal failure in Europe, XXII. 1991. Nephrol Dial Transplant. 1992;7(suppl 2):7-35.
2. Foley RN, Parfrey PS. Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32: S112-S119.
3. Locatelli F, Del Vecchio L, Manzoni C. Morbidity and mortality on maintenance haemodialysis. Contrib Nephrol. 1998;124:166-189.
4. Levey AS, Eknoyan G. Cardiovascular disease in chronic renal disease. Nephrol Dial Transplant. 1999;14:828-833.
5. Ibels LS, Alfrey AC, Huffer WE, Craswell PW, Anderson JT, Weil R III. Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med. 1979;66:790-796.
6. Barenbrock M, Spieker C, Laske V, Heidenreich S, Hohage H. Bachmann J. Hoeks AP, Rann KH. Studies of the vessel wall properties in hemodialysis patients. Kidney Int. 1994;45:1397-1400.
7. Kawagishi T, Nishizawa Y, Konishi T, Kawasaki K, Emoto M, Shoji T, Tabata T, Inoue T, Morii H. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int. 1995;48:820-826.
8. Pascazio L, Bianco F, Giorgini A, Galli G, Curri G, Panzetta G. Echo color Doppler imaging of carotid vessels in hemodialysis patients: evidence of high levels of atherosclerotic lesions. Am J Kidney Dis. 1996;28:713-720.
9. London G, Drueke T. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int. 1997;51:1678-1695.
10. Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol. 1997;30:325-333.
11. Cooke JP, Dzau VJ. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med. 1997;48:489-509.
12. Drexler H. Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis. 1997;39:287-324.
13. Joannides R. Bakkali EH, LeRoy F, Rivault O, Godin M, Moore N, Fillastre JP, Thuillez C. Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis. Nephrol Dial Transplant. 1997; 12:2623-2628.
14. van Guldener C, Janssen MJ, Lambert J, terWee PM, Jakobs C, Donker AJ, Stehouwer CD. No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients. Nephrol Dial Transplant. 1998;13:106-112.
15. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest. 1997;100:2153-2157.
16. Becker BN, Himmelfarb J, Henrich WL, Hakim RM. Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol. 1997;8:475-486.
17. Itabe H, Yamamoto H, Imanaka T, Shimamura K, Uchiyama H, Kimura J, Sanaka T, Hata Y, Takano T. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J Lipid Res. 1996;37:45-53.
18. Holvoel P, Donck J, Landeloos M, Brouwers E, Luijtens K, Arnout J, Lesaffre E, Vanrenterghem Y, Collen D. Correlation between oxidized low density lipoproleins and von Willebrand factor in chronic renal failure. Thromb Haemost. 1996;76:663-669.
19. Salem M, Ivanovich P, Mujais S. Biocompatibility of dialysis membranes. Contrib Nephrol. 1993;103:55-64.
20. Ritz E, Deppisch R, Stier E, Mansch G. Atherogenesis and cardiac death: are they related to dialysis procedure and biocompatibility? Nephrol Dial Transplant. 1994;2:165-172.
21. Lazarus JM, Owen WF. Role of bioincompatibility in dialysis morbidity and mortality. Am J Kidney Dis. 1994;24:1019-1032.
22. Haag-Weber M, Horl WH. Dysfunction of polymorphonuclear leukocytes in uremia. Semin Nephrol. 1996;16:192-201.
23. Hoenich NA. Platelet and leucocyte behaviour during haemodialysis. Contrib Nephrol. 1999;125:120-132.
24. Peuchant E, Carbonneau MA, Dubourg L, Thomas MJ, Perromat A, Vallot C, Clerc M. Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: vitamins A, E, and iron status. Kidney Int. 1994;45:339-346.
25. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Nephrol. 1995;44:1135-1138.
26. Daschner M, Lenhartz H, Botticher D, Schaefer F, Wollschlager M, Mehls O, Leichsenring M. Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. Kidney Int. 1996;50:1268-1272.
27. Hultqvist M, Hegbrant J, Nilsson-Thorell C, Lindholm T, Nilsson P, Linden T, Hultqvist-Bengtsson U. Plasma concentrations of vitamin C, vilamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis. Clin Nephrol. 1997;47:37-46.
28. Buoncristiani U, Galli F, Rovidati S, Albertini MC, Campus G, Canestrari F. Oxidative damage during hemodialysis using a vitamin-E-modified dialysis membrane: a preliminary characterization. Nephron. 1997;77:57-61.
29. Galli F, Rovidati S, Chiarantini L, Campus G, Canestrari F, Buoncristiani U. Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter. Kidney Int. 1998;54:580-589.
30. Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T. Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acid. Clin Sci. 1999;96:235-239.
31. Itabe H, Yamamoto H, Suzuki M, Kawai Y, Nakagawa Y, Suzuki A, Imanaka T, Takano T. Oxidized phosphatidylcholines that modify proteins: analysis by monoclonal antibody against oxidized low density lipoprotein. J Biol Chem. 1996;271:33208-33217.
32. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation. 1997;95:76-82.
33. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Luscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91:1314-1319.
34. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339:572-575.
35. Kielstein JT, Böger RH, Bode-Böger SM, Schaffer J, Barbey M, Koch KM, Frölich JC. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol. 1999;10:594-600.
36. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, Imaizumi T. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation. 1999;99:1141-1146.
37. Rysz J, Luciak M, Kedziora J, Blaszczyk J, Sibinska E. Nitric oxide release in the peripheral blood during hemodialysis. Kidney Int. 1997;51:294-300.
38. Roccatello D, Mengozzi G, Allleri V, Pignone E, Menegatti E, Cavalli G, Cesano G, Rossi D, Formica M, Inconis T, Martina G, Paradisi L, Sena LM, Piccoli G. Early increase in blood nitric oxide, detected by electron paramagnetic resonance as nitrosylhaemoglobin, in haemodialysis. Nephrol Dial Transplant. 1997;12:292-297.
39. Amore A, Bonaudo R, Ghigo D, Arese M, Costamagna C, Cirina P, Gianoglio B, Perugini L, Coppo R. Enhanced production of nitric oxide by blood-dialysis membrane interaction. J Am Soc Nephrol. 1995;6: 1278-1283.
40. Diaz MN, Frei B, Vita JA, Keaney J Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med. 1997;337:408-416.
41. Hand MF, Haynes WG, Webb DJ. Hemodialysis, and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction. Kidney Int. 1998;53:1068-1077.
42. Boegehold MA. Heterogeneity of endothelial function within the circulation. Curr Open Nephrol Hypertens. 1998;7:71-78.
43. Luscher TF, Noll G. Endothelial function as an end-point in interventional trials: concepts, methods and current data. J Hypertens. 1996;14: S111-S119.